kwic
compared+to
compared+to
right
off
ON
19
1
100
500
strict
ELIZA cgi-bash version rev. 1.91
- Medical English LInking keywords finder for the PubMed Zipped Archive (ELIZA) -
return
kwic search for compared to out of >500 occurrences
270181 occurrences (No.97 in the rank) during 5 years in the PubMed. [no cache] 500 found
--- ABSTRACT ---
--- ABSTRACT END ---
[frequency of next (right) word to compared to]
270181 occurrences (No.97 in the rank) during 5 years in the PubMed. [no cache] 500 found
| 19) Immunohistochemistry technique showed that EGFR vIII is highly expressed in benign tumors as compared to the atypical meningioma with a highly significant p-value (p<0.05). |
| PMID:34582442 DOI:10.1371/journal.pone.0255133 |
| 2021 PloS one |
| * Exploring the role of epidermal growth factor receptor variant III in meningeal tumors. |
| - Meningioma is the second most common type of intracranial brain tumor. Immunohistochemical techniques have shown prodigious results in the role of epidermal growth factor receptor variant III (EGFR vIII) in glioma and other cancers. However, the role of EGFR vIII in meningioma is still in question. This study attempt the confer searches for the position attained by EGFR vIII in progression and expression of meningioma. Immunohistochemistry technique showed that EGFR vIII is highly expressed in benign tumors as compared to the atypical meningioma with a highly significant p-value (p<0.05). Further analysis by flow cytometry results supported these findings thus presented high intensity of EGFR vIII in low grades of meningioma. The study revealed that the significant Ki 67 values, to predictor marker for survival and prognosis of the patients. Higher expression of EGFR vIII in low grades meningiomas as compared to high-grade tumors indicate towards its oncogenic properties. To our knowledge, limited studies reported in literature expressing the EGFR vIII in meningioma tumors. Hence, Opinions regarding the role that EGFR vIII in tumorigenesis and tumor progression are clearly conflicting and, therefore, it is crucial not only to find out its mechanism of action, but also to definitely identify its role in meningioma. |
[
right
kwic]
(1)95  the |
(14)5 conventional |
(27)2 ER+ |
(40)2 measures |
| (2)19 other |
(15)5 placebo |
(28)2 LONG |
(41)2 patients |
| (3)18 those |
(16)5 that |
(29)2 PLWH |
(42)2 placebo, |
| (4)16 healthy |
(17)4 standard |
(30)2 TM |
(43)2 poor |
| (5)13 a |
(18)4 women |
(31)2 TomTec |
(44)2 swabs |
| (6)13 controls |
(19)3 group |
(32)2 WT |
(45)2 therapy |
| (7)10 control |
(20)3 males |
(33)2 allogeneic |
(46)2 traditional |
| (8)7 baseline |
(21)3 no |
(34)2 any |
(47)2 uninfected |
| (9)7 their |
(22)3 non-obese |
(35)2 children |
(48)2 untreated |
| (10)6 control, |
(23)3 wild-type |
(36)2 expert |
(49)2 usual |
| (11)6 individuals |
(24)2 B-385 |
(37)2 females |
|
| (12)6 normal |
(25)2 CON |
(38)2 field |
|
| (13)5 controls, |
(26)2 CS- |
(39)2 irradiated |
add keyword
--- WordNet output for compared ---